ROYAL BANK OF CANADA - PROCESSA PHARMACEUTICALS INC ownership

PROCESSA PHARMACEUTICALS INC's ticker is PCSA and the CUSIP is 74275C205. A total of 20 filers reported holding PROCESSA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of PROCESSA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$12,00046,382
+30616.6%
0.00%
Q2 2023$0
-100.0%
151
-84.9%
0.00%
Q4 2022$1,000
-50.0%
1,000
-1.5%
0.00%
Q3 2022$2,000
-33.3%
1,015
+1.5%
0.00%
Q2 2022$3,0000.0%1,0000.0%0.00%
Q1 2022$3,000
-40.0%
1,0000.0%0.00%
Q4 2021$5,0001,0000.00%
Other shareholders
PROCESSA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Solas Capital Management, LLC 196,150$961,0000.68%
AIGH Capital Management LLC 303,703$1,488,0000.45%
Worth Venture Partners, LLC 70,954$348,0000.17%
ESSEX INVESTMENT MANAGEMENT CO LLC 73,180$359,0000.04%
Verdence Capital Advisors LLC 63,227$310,0000.04%
Coastal Bridge Advisors, LLC 32,500$159,0000.03%
Vectors Research Management, LLC 4,000$20,0000.00%
Janney Montgomery Scott LLC 46,231$227,0000.00%
NORTHERN TRUST CORP 15,401$75,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of PROCESSA PHARMACEUTICALS INC shareholders